V, P., G, B., R, P., L, F., A, T., C, C., . . . M, F. (2024). Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease. Journal of neurology, 271(1), 575. https://doi.org/10.1007/s00415-023-11983-w
Chicago Style (17th ed.) CitationV, Pieri, et al. "Liquid Biopsy of Cerebrospinal Fluid Enabling the Detection and Therapeutic Targeting of the BRAFV600E Mutation in a Patient with Overlapping Erdheim-Chester/Rosai-Dorfman Disease." Journal of Neurology 271, no. 1 (2024): 575. https://doi.org/10.1007/s00415-023-11983-w.
MLA (9th ed.) CitationV, Pieri, et al. "Liquid Biopsy of Cerebrospinal Fluid Enabling the Detection and Therapeutic Targeting of the BRAFV600E Mutation in a Patient with Overlapping Erdheim-Chester/Rosai-Dorfman Disease." Journal of Neurology, vol. 271, no. 1, 2024, p. 575, https://doi.org/10.1007/s00415-023-11983-w.